Introduction

The UK government has six months to decide whether to terminate a $400 million deal between the National Health Service (NHS) and American software company Palantir. The NHS Greater Manchester health care board has declined to adopt Palantir's Federated Data Platform (FDP), choosing to stick with a home-spun platform developed over a decade. This decision has sparked a national debate on the NHS's relationship with US-made technology.

The Single English County Saying No to Palantir

NHS Greater Manchester's Decision

NHS Greater Manchester has chosen to stick with its own home-spun platform over Palantir's Federated Data Platform (FDP), citing concerns about trust and functionality. The board claims that its own platform is functionally superior and more trusted by the public. According to NHS Greater Manchester's chief data and analytics officer, Matt Hennessey, a technically strong platform will struggle to realize value if clinicians, data controllers, patients, or the public do not trust it. The board's decision has fed into a national debate over whether the government should terminate the NHS contract early.

The Federated Data Platform (FDP)

Palantir's FDP is a federated data platform designed to ingest and organize the tangle of health data produced across the country. The platform consists of a national pool of health data meant to help identify care deficiencies, and a bunch of local databases that individual regions can use to perform analyses and develop tools specific to their needs. The various components all share the same underlying technology scaffolding, in theory making it possible for tools developed in one corner of the country to be readily adopted in another.

The Debate Over US-Made Technology

The NHS's relationship with Palantir has become a flashpoint in the UK, drawing protests, petitions, parliamentary inquiries, and a reported rebellion among NHS workers. Other European nations, increasingly at loggerheads with the Trump administration, are also reevaluating their relationships with Palantir in a bid to minimize their dependence on US-made technology.

Conclusion

The NHS Greater Manchester health care board's decision to stick with its own platform over Palantir's Federated Data Platform (FDP) has sparked a national debate over the NHS's relationship with US-made technology.

Comments